STOXX 600

Genmab Tops Europe's Market: Stock Jumps 13% as Its Cancer Drug Posts 28-Month Survival Data

2026-10-26

Genmab stock: the short answer Genmab shares jumped 13.7% on Monday, October 26, 2026, to the top of Europe's STOXX 600 index , after the Danish biotech reported updated Phase 2 data for its experi...